Therapeutic Strategies against Ebola Virus Infection
Since the 2014–2016 epidemic, Ebola virus (EBOV) has spread to several countries and has become a major threat to global health. EBOV is a risk group 4 pathogen, which imposes significant obstacles for the development of countermeasures against the virus. Efforts have been made to develop anti-EBOV...
主要な著者: | , , , |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
MDPI AG
2022-03-01
|
シリーズ: | Viruses |
主題: | |
オンライン・アクセス: | https://www.mdpi.com/1999-4915/14/3/579 |